Medical News

RSS

Innovation of the Year: Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software

3M Health Care and Zargis Medical, a majority-owned subsidiary of Speedus Corp. (Nasdaq:SPDE), announced today that the 3M™ Littmann® Electronic Stethoscope Model 3200 with Zargis Cardioscan™ software was named Popular Science’s “Innovation of the Year.” This prestigious honor, part of the publication’s annual “Best of What’s New Awards,” highlights outstanding innovation, vision and execution in technologic, scientific and medical advances for the year.

12 Nov 2009

Biostar Pharmaceuticals reports financial results for the third quarter of 2009

Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced financial results the third quarter ended September 30, 2009.

12 Nov 2009

arGentis Pharmaceuticals to commence human clinical evaluation of ARG301 oral altered peptide ligand

arGentis Pharmaceuticals, LLC today announced that it will collaborate with the University of Tennessee Health Science Center (UTHSC) and the Veterans Affairs Medical Center of Memphis (VAMC) to initiate the first human clinical evaluation of an oral altered peptide ligand (APL), ARG301, in a Phase I study of Rheumatoid Arthritis patients.

12 Nov 2009

Third-quarter 2009 results announced by Catalyst Pharmaceutical

Catalyst Pharmaceutical Partners, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.

12 Nov 2009

American Medical Alert announces operating results for the third quarter of 2009

American Medical Alert Corp. a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter and nine months ended September 30, 2009.

12 Nov 2009

Hyland Software's OnBase rated as one of the top DMI system solutions on the market

Your healthcare organization is in the market for a document management and imaging (DMI) system. There are dozens of vendors in the space, and each offers something at least slightly different than the others. It's a huge investment and there isn't room for error. Where do you begin your search for a standout vendor and product? Perhaps with a new report from KLAS titled, "Enterprise DMI: Finding the Right Stepping-Stone to Full EMR."

12 Nov 2009

Artificially increasing selenium status above the level required is unwarranted, study calls for further research

A new study from the University of Warwick has discovered taking too much of the essential mineral selenium in your diet can increase your cholesterol by almost 10%.

12 Nov 2009

Gene within the pancreas affecting insulin secretion discovered

How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universities. Their work opens the way for a new understanding of possible paths to battle diabetes and diabetes-related health problems, which are on the rise all over the world.

12 Nov 2009

Novadaq announces financial results for the third quarter of 2009

Novadaq® Technologies Inc., a developer of real-time imaging systems for use in the operating room, today announced 2009 third quarter revenues of $1,723,000 compared to revenue of $3,311,000 in third quarter 2008. In accordance with corporate policy, a previously reported order in excess of $2,000,000 has not been recorded in sales due to cash not yet received.

12 Nov 2009

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today.

12 Nov 2009

Addus HomeCare announces financial results for the third quarter of 2009

Addus HomeCare Corporation, a comprehensive provider of a broad range of social and medical services in the home, announced today its financial results for the third quarter and nine months ended September 30, 2009.

12 Nov 2009

Detailed review findings of EMPOWER study to evaluate the Maestro System released

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today announced preliminary findings from its ongoing detailed review of its EMPOWER™ study, a randomized, double-blind, controlled pivotal study designed to evaluate the safety and efficacy of the Maestro® System in the treatment of obesity.

12 Nov 2009

Spectrum Pharmaceuticals reports consolidated revenues of $7.1M for the third quarter of 2009

Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for the third quarter ended September 30, 2009.

12 Nov 2009

USPTO issues patent number to Vermillion's biomarkers for detecting ovarian cancer

Vermillion, Inc., a molecular diagnostics company, today announced that the U.S. Patent Office (USPTO) has issued patent number 7,605,003 titled "Use of biomarkers for detecting ovarian cancer" to the Company for the discovery of biomarkers for ovarian cancer.

12 Nov 2009

Second-quarter fiscal 2010 results announced by Cyanotech

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the second quarter and first six months of fiscal 2010, ended September 30, 2009.

12 Nov 2009

Arrayit Diagnostics develops diagnostic tests for early cancer detection

Arrayit Corporation announced today that the company's majority owned subsidiary, Arrayit Diagnostics, Inc., will launch the most intensive marketing campaign in the company's thirteen-year history. The company is currently developing several diagnostic tests that will provide early detection for cancers, neurodegenerative diseases and other disease states.

12 Nov 2009

Financial results for third-quarter 2009 announced by Spectral Diagnostics

Spectral Diagnostics Inc., today announced its financial results for the third quarter ended September 30, 2009.

12 Nov 2009

MAP Pharmaceuticals to sell up to $60 million of its registered common stock to Azimuth Opportunity

MAP Pharmaceuticals, Inc. today announced that it has secured a committed equity financing facility under which it may sell up to $60 million of its registered common stock to Azimuth Opportunity Ltd. MAP Pharmaceuticals is not obligated to utilize any of the $60 million facility, which has a term of 24 months.

12 Nov 2009

Meridian Bioscience announces fiscal 2009 fourth-quarter and full-year financial results

Net sales for the fourth quarter of fiscal 2009 were $42,461,000 as compared to $36,475,000 for the same period of the prior fiscal year, an increase of 16%. Net earnings for the fourth quarter of fiscal 2009 were $8,930,000, or $ 0.22 per diluted share, up 16% over the fourth quarter of fiscal 2008.

12 Nov 2009

Review of Mersana Therapeutics's lead compound, XMT-1001 to be published

Mersana Therapeutics, a platform-based cancer therapeutics company, announced today that a review of the Company's lead compound, XMT-1001, will appear in the November 12, 2009 special issue of Advanced Drug Delivery Reviews on Polymer Therapeutics: Clinical Applications and Challenges for Development.

12 Nov 2009

Medical News

Innovation of the Year: Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software

Biostar Pharmaceuticals reports financial results for the third quarter of 2009

arGentis Pharmaceuticals to commence human clinical evaluation of ARG301 oral altered peptide ligand

Third-quarter 2009 results announced by Catalyst Pharmaceutical

American Medical Alert announces operating results for the third quarter of 2009

Hyland Software's OnBase rated as one of the top DMI system solutions on the market

Artificially increasing selenium status above the level required is unwarranted, study calls for further research

Gene within the pancreas affecting insulin secretion discovered

Novadaq announces financial results for the third quarter of 2009

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Addus HomeCare announces financial results for the third quarter of 2009

Detailed review findings of EMPOWER study to evaluate the Maestro System released

Spectrum Pharmaceuticals reports consolidated revenues of $7.1M for the third quarter of 2009

USPTO issues patent number to Vermillion's biomarkers for detecting ovarian cancer

Second-quarter fiscal 2010 results announced by Cyanotech

Arrayit Diagnostics develops diagnostic tests for early cancer detection

Financial results for third-quarter 2009 announced by Spectral Diagnostics

MAP Pharmaceuticals to sell up to $60 million of its registered common stock to Azimuth Opportunity

Meridian Bioscience announces fiscal 2009 fourth-quarter and full-year financial results

Review of Mersana Therapeutics's lead compound, XMT-1001 to be published

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News